Skip to main content

JOHNSON & JOHNSON

CIK 0000200406

JNJNYSEPharmaceutical Preparations (SIC 2834)Fiscal year ends in early January

Fiscal 2025

From the 10-K filed 2026-02-11, year ended 2025-12-28

Revenue

$94.19B

Up 6.0% on 2024

Net income

$26.80B

Up 90.6% on 2024

Operating income

$21.59B

As reported

10-K filed 2015-02-24

Diluted EPS

$11.03

Per share, as reported

Free cash flow

$19.70B

Calculated

Free cash flow is not a line in the filing. It is calculated as operating cash flow minus capital expenditures for the same year. Revenue uses the tag RevenueFromContractWithCustomerExcludingAssessedTax.

Six years of revenue and net income

RevenueNet income

Every year, with its filing

US dollars in millions. Each accession number opens the filing on sec.gov.
Fiscal yearRevenueNet incomeFormFiled
202594,19326,80410-K2026-02-11
202488,82114,06610-K2025-02-13
202385,15935,15310-K2024-02-16
202279,99017,94110-K2024-02-16
202178,74020,87810-K2024-02-16
202082,58414,71410-K2021-02-22

Get these numbers yourself

The shared demo key works for a quick try. A free key gives 100 calls a day, and agents can pay 0.02 USDC a call with x402.

Read the API docs

curl

curl -H "Authorization: Bearer demo" \
  "https://api.netnestdesign.com/v1/history/JNJ/revenue?period=annual&limit=6"

Python

import requests

r = requests.get(
    "https://api.netnestdesign.com/v1/fundamentals/JNJ",
    params={"metrics": "revenue,net_income,eps_diluted", "period": "annual"},
    headers={"Authorization": "Bearer demo"},
    timeout=30,
)
for row in r.json()["data"]:
    print(row["metric"], row["value"], row["form"], row["filed_date"])

Data from SEC filings. Not investment advice.